Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02752984
NCT02752984UnknownNot Applicable

Prospective Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion

Fondazione IRCCS Policlinico San Matteo di Pavia1 site in 1 country400 target enrollmentStarted: April 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
400
Locations
1
Primary Endpoint
Early Deep Vein Thrombosis incidence assessed with weekly ultrasound examination
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Deep Vein Thrombosis (DVT) is one of the most important complications after Peripherally Inserted Central Catheter (PICC) insertion. This study goals are to understand when and why DVT develops.

Detailed Description

Deep Vein Thrombosis (DVT) is one of the most important complications after Peripherally Inserted Central Catheter (PICC) insertion. This study goals are to understand when and why DVT develops. Patients will be studied with ultrasound for 4 weeks after PICC insertion, one visit a week. The final outcome of PICCs will be collected.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Peripherally Inserted Central Catheter insertion

Exclusion Criteria

  • •Pre-existing Deep Vein Thrombosis

Outcomes

Primary Outcomes

Early Deep Vein Thrombosis incidence assessed with weekly ultrasound examination

Time Frame: 4 weeks

Secondary Outcomes

  • Factors which may be correlated to Deep Vein Thrombosis development: previous Deep Vein Thrombosis(4 weeks)
  • Factors which may be correlated to Deep Vein Thrombosis development: obesity (Body Mass Index)(4 weeks)
  • Factors which may be correlated to Deep Vein Thrombosis development: Heparin-induced thrombocytopenia(4 weeks)
  • Factors which may be correlated to Deep Vein Thrombosis development: cancer(4 weeks)
  • Overall Deep Vein Thrombosis incidence(6 months)

Investigators

Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michele Pagani

MD

Fondazione IRCCS Policlinico San Matteo di Pavia

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal ResectionThoracic SurgeryEsophageal CancerVenous Thromboembolism
NCT03115541McMaster University187
Completed
Phase 4
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day EnoxaparinVenous Thromboembolic DiseaseDeep Vein ThrombosisPulmonary Embolism
NCT01729559Scripps Health495
Terminated
Not Applicable
Deep Venous Thrombosis After Hepatobiliopancreatic SurgeryHepatectomyPancreatectomyVenous ThrombosisPulmonary Embolism
NCT02649023Technische Universität Dresden76
Completed
Not Applicable
The Prevalence and Incidence of DVT in General ICUDeep Venous Thrombosis
NCT03286985Masaryk Hospital Krajská zdravotní a.s.200
Recruiting
Not Applicable
Venous Thromboembolism in Primary Pancreatic Tumour ResectionPancreatic Ductal AdenocarcinomaPancreatic CancerVenous Thromboembolism
NCT05964621University of Thessaly64
Study on the Incidence of Early Deep Vein... | Clinical Trial